SANOFI-AVENTIS (EPA:SAN) | WebDisclosure

Basculer en Français

9815	Companies
196879	Keywords
127951	Articles
104707	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 09/11/2024 at 07:00, 1 year 4 months ago

Press Release: Dupixent is the first and only biologic to achieve significant improvements in disease remission and symptoms in bullous pemphigoid positive pivotal study
Dupixent achieves significant improvements in disease remission and symptoms in bullous pemphigoid study. Study met primary and key secondary endpoints with beneficial steroid-sparing effect

Dupixent Bullous Pemphigoid Disease Remission Symptoms Steroid-sparing Effect
BRIEF

published on 08/09/2024 at 21:16, 1 year 5 months ago

Sanofi publie les chiffres de son capital et de ses droits de vote en juillet 2024

Autorité Des Marchés Financiers Droits De Vote Capital Social Juillet 2024 Actions Sanofi
BRIEF

published on 08/09/2024 at 21:16, 1 year 5 months ago

Sanofi publishes its capital and voting rights figures for July 2024

Share Capital Voting Rights Financial Markets Authority July 2024 Sanofi Actions
PRESS RELEASE

published on 08/09/2024 at 21:11, 1 year 5 months ago

Sanofi: Informations relatives au nombre de droits de vote et d'actions - Juillet 2024
Publication des informations relatives au nombre total de droits de vote et d’actions de Sanofi selon l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’AMF

Droits De Vote Actions AMF Informations Financières Sanofi
PRESS RELEASE

published on 08/09/2024 at 21:11, 1 year 5 months ago

Sanofi: Information concerning the total number of voting rights and shares - July 2024
Sanofi discloses total voting rights and shares as per French Commercial Code and AMF Regulations for July 31, 2024

French Commercial Code Total Voting Rights AMF Regulations Sanofi July 31 2024
BRIEF

published on 08/08/2024 at 07:05, 1 year 5 months ago

Sarclisa améliore la survie sans progression pour les patients atteints de myélome multiple éligibles à une transplantation

Étude Clinique Sanofi Myélome Multiple Sarclisa Survie Sans Progression
BRIEF

published on 08/08/2024 at 07:05, 1 year 5 months ago

Sarclisa Improves Progression-Free Survival for Multiple Myeloma Patients Eligible for Transplant

Clinical Study Sanofi Multiple Myeloma Sarclisa Progression-free Survival
PRESS RELEASE

published on 08/08/2024 at 07:00, 1 year 5 months ago

Communiqué : Le traitement d’induction par Sarclisa a démontré une amélioration significative de la survie sans progression chez les patients atteints d’un myélome multiple nouvellement diagnostiqué et éligibles à une transplantation
Le traitement d’induction par Sarclisa montre une amélioration significative de la survie sans progression chez les patients atteints de myélome multiple nouvellement diagnostiqués et éligibles à une transplantation

Myélome Multiple Sarclisa Survie Sans Progression Traitement D'induction GMMG-HD7
PRESS RELEASE

published on 08/08/2024 at 07:00, 1 year 5 months ago

Press Release: Sarclisa induction treatment demonstrated significantly improved progression-free survival in patients with newly diagnosed multiple myeloma eligible for transplant
New data shows Sarclisa induction therapy improves progression-free survival in transplant-eligible newly diagnosed multiple myeloma patients. GMMG-HD7 study results are promising for Sarclisa as part of frontline treatment

Multiple Myeloma Sarclisa Progression-free Survival GMMG-HD7 Study Frontline Treatment
BRIEF

published on 07/22/2024 at 22:10, 1 year 6 months ago

Sanofi Announces Total Number of Voting Rights and Shares for June 2024

Voting Rights French Commercial Code Financial Regulations Sanofi Shares 2024

Accesswire

Published on 02/05/2026 at 18:50, 1 hour 20 minutes ago

Athena Gold Provides Exploration Update From Nevada and Ontario
Published on 02/05/2026 at 17:35, 2 hours 35 minutes ago

Pentagon I Capital Corp. Enters into Letter Agreement to Complete Qualifying Transaction with Prospectiva Resources Ltd.
Published on 02/05/2026 at 16:40, 3 hours 30 minutes ago

Relevant Gold Appoints Larry Taddei to Board of Directors and Mal Karwowska as Strategic Advisor
Published on 02/05/2026 at 15:45, 4 hours 25 minutes ago

American Critical Minerals Recaps a Highly Successful 6 Months and Files Amended and Restated Technical Report
Published on 02/05/2026 at 15:10, 5 hours ago

Electric Metals (USA) Limited Announces Change of Auditor

View all ACCESSWIRE

EQS Group

Published on 02/05/2026 at 19:27, 42 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/05/2026 at 18:46, 1 hour 23 minutes ago

EQS-Adhoc: Mayr-Melnhof Karton AG: Impairment requirements impact profit for the financial year 2025
Published on 02/05/2026 at 18:09, 2 hours ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/05/2026 at 17:55, 2 hours 14 minutes ago

Piramal Critical Care and Blue-Zone Technologies collaborate to capture, collect and recycle waste anaesthesia gas
Published on 02/05/2026 at 17:40, 2 hours 30 minutes ago

BROADPEAK SA: Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social au 01.02.26.

Les Echos

Published on 02/05/2026 at 19:24, 45 minutes ago

Minutes of the Combined General Meeting
Published on 02/05/2026 at 19:24, 45 minutes ago

Compte-Rendu de l’Assemblée Générale Mixte
Published on 02/05/2026 at 19:15, 55 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 02/05/2026 at 19:15, 55 minutes ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES JANVIER 2026
Published on 02/05/2026 at 19:15, 55 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE